Novel prenyloxy chalcones as potential leishmanicidal and trypanocidal agents: Design, synthesis and evaluation

José C. Espinoza-Hicks, Karla Fabiola Chacón-Vargas, Jessica L. Hernández-Rivera, Benjamín Nogueda-Torres, Joaquín Tamariz, Luvia Enid Sánchez-Torres, Alejandro Camacho-Dávila

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

© 2019 Elsevier Masson SAS The available drugs for treating Leishmaniasis and American trypanosomiasis have high toxicity and multiple side effects, among other problems. More effective and less toxic treatments are urgently needed. A series of chalcones that contained a prenyloxy or geranyloxy substituent was synthesized and characterized. Each substituent was attached to the A ring in some compounds and to the B ring in others, with additional substituents placed on the chalcone moiety. The present aim was to evaluate the effect of the substitution pattern on leishmanicidal and trypanocidal activity. When tested at a single concentration, the compounds exerting a metabolic inhibition close to or exceeding 50% for Leishmania mexicana were 11, 17 and 12, and for Trypanosoma cruzi were 11, 17, 15 and 26. Upon determining the selectivity index (SI =IC 50 /CC 50 ), the values were 80.9, 1.24 and 55.12 for 11, 17 and 12 (respectively) versus L. mexicana, and 75.1, 1.43, 27.36 and 33.52 for 11, 17, 15 and 26 (respectively) versus T. cruzi. Structural isomers 11 and 17 showed activity for both the L. mexicana and T. cruzi strains, though the greater cytotoxic activity of 17 led to a lower SI. Compounds 12, 15 and 26 were species specific. For T. cruzi, the SI was higher for 11, 15 and 26 than for the reference drugs nifurtimox and benznidazole. The examination of promastigote morphology after exposing L. mexicana and T. cruzi to 11 revealed a decrease in cell density. The current findings suggest that 11 could be a useful lead compound for further SAR studies.
Original languageAmerican English
Pages (from-to)402-413
Number of pages360
JournalEuropean Journal of Medicinal Chemistry
DOIs
StatePublished - 1 Apr 2019

Fingerprint

Trypanocidal Agents
Chalcones
Leishmania mexicana
Trypanosoma cruzi
Nifurtimox
Lead compounds
Chalcone
Poisons
Isomers
Pharmaceutical Preparations
Toxicity
Substitution reactions
Leishmaniasis
Chagas Disease
Cell Count

Cite this

@article{c3cca06aef1c4691b4e365318381ac93,
title = "Novel prenyloxy chalcones as potential leishmanicidal and trypanocidal agents: Design, synthesis and evaluation",
abstract = "{\circledC} 2019 Elsevier Masson SAS The available drugs for treating Leishmaniasis and American trypanosomiasis have high toxicity and multiple side effects, among other problems. More effective and less toxic treatments are urgently needed. A series of chalcones that contained a prenyloxy or geranyloxy substituent was synthesized and characterized. Each substituent was attached to the A ring in some compounds and to the B ring in others, with additional substituents placed on the chalcone moiety. The present aim was to evaluate the effect of the substitution pattern on leishmanicidal and trypanocidal activity. When tested at a single concentration, the compounds exerting a metabolic inhibition close to or exceeding 50{\%} for Leishmania mexicana were 11, 17 and 12, and for Trypanosoma cruzi were 11, 17, 15 and 26. Upon determining the selectivity index (SI =IC 50 /CC 50 ), the values were 80.9, 1.24 and 55.12 for 11, 17 and 12 (respectively) versus L. mexicana, and 75.1, 1.43, 27.36 and 33.52 for 11, 17, 15 and 26 (respectively) versus T. cruzi. Structural isomers 11 and 17 showed activity for both the L. mexicana and T. cruzi strains, though the greater cytotoxic activity of 17 led to a lower SI. Compounds 12, 15 and 26 were species specific. For T. cruzi, the SI was higher for 11, 15 and 26 than for the reference drugs nifurtimox and benznidazole. The examination of promastigote morphology after exposing L. mexicana and T. cruzi to 11 revealed a decrease in cell density. The current findings suggest that 11 could be a useful lead compound for further SAR studies.",
author = "Espinoza-Hicks, {Jos{\'e} C.} and Chac{\'o}n-Vargas, {Karla Fabiola} and Hern{\'a}ndez-Rivera, {Jessica L.} and Benjam{\'i}n Nogueda-Torres and Joaqu{\'i}n Tamariz and S{\'a}nchez-Torres, {Luvia Enid} and Alejandro Camacho-D{\'a}vila",
year = "2019",
month = "4",
day = "1",
doi = "10.1016/j.ejmech.2019.02.028",
language = "American English",
pages = "402--413",
journal = "European Journal of Medicinal Chemistry",
issn = "0223-5234",
publisher = "Elsevier Masson SAS",

}

Novel prenyloxy chalcones as potential leishmanicidal and trypanocidal agents: Design, synthesis and evaluation. / Espinoza-Hicks, José C.; Chacón-Vargas, Karla Fabiola; Hernández-Rivera, Jessica L.; Nogueda-Torres, Benjamín; Tamariz, Joaquín; Sánchez-Torres, Luvia Enid; Camacho-Dávila, Alejandro.

In: European Journal of Medicinal Chemistry, 01.04.2019, p. 402-413.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Novel prenyloxy chalcones as potential leishmanicidal and trypanocidal agents: Design, synthesis and evaluation

AU - Espinoza-Hicks, José C.

AU - Chacón-Vargas, Karla Fabiola

AU - Hernández-Rivera, Jessica L.

AU - Nogueda-Torres, Benjamín

AU - Tamariz, Joaquín

AU - Sánchez-Torres, Luvia Enid

AU - Camacho-Dávila, Alejandro

PY - 2019/4/1

Y1 - 2019/4/1

N2 - © 2019 Elsevier Masson SAS The available drugs for treating Leishmaniasis and American trypanosomiasis have high toxicity and multiple side effects, among other problems. More effective and less toxic treatments are urgently needed. A series of chalcones that contained a prenyloxy or geranyloxy substituent was synthesized and characterized. Each substituent was attached to the A ring in some compounds and to the B ring in others, with additional substituents placed on the chalcone moiety. The present aim was to evaluate the effect of the substitution pattern on leishmanicidal and trypanocidal activity. When tested at a single concentration, the compounds exerting a metabolic inhibition close to or exceeding 50% for Leishmania mexicana were 11, 17 and 12, and for Trypanosoma cruzi were 11, 17, 15 and 26. Upon determining the selectivity index (SI =IC 50 /CC 50 ), the values were 80.9, 1.24 and 55.12 for 11, 17 and 12 (respectively) versus L. mexicana, and 75.1, 1.43, 27.36 and 33.52 for 11, 17, 15 and 26 (respectively) versus T. cruzi. Structural isomers 11 and 17 showed activity for both the L. mexicana and T. cruzi strains, though the greater cytotoxic activity of 17 led to a lower SI. Compounds 12, 15 and 26 were species specific. For T. cruzi, the SI was higher for 11, 15 and 26 than for the reference drugs nifurtimox and benznidazole. The examination of promastigote morphology after exposing L. mexicana and T. cruzi to 11 revealed a decrease in cell density. The current findings suggest that 11 could be a useful lead compound for further SAR studies.

AB - © 2019 Elsevier Masson SAS The available drugs for treating Leishmaniasis and American trypanosomiasis have high toxicity and multiple side effects, among other problems. More effective and less toxic treatments are urgently needed. A series of chalcones that contained a prenyloxy or geranyloxy substituent was synthesized and characterized. Each substituent was attached to the A ring in some compounds and to the B ring in others, with additional substituents placed on the chalcone moiety. The present aim was to evaluate the effect of the substitution pattern on leishmanicidal and trypanocidal activity. When tested at a single concentration, the compounds exerting a metabolic inhibition close to or exceeding 50% for Leishmania mexicana were 11, 17 and 12, and for Trypanosoma cruzi were 11, 17, 15 and 26. Upon determining the selectivity index (SI =IC 50 /CC 50 ), the values were 80.9, 1.24 and 55.12 for 11, 17 and 12 (respectively) versus L. mexicana, and 75.1, 1.43, 27.36 and 33.52 for 11, 17, 15 and 26 (respectively) versus T. cruzi. Structural isomers 11 and 17 showed activity for both the L. mexicana and T. cruzi strains, though the greater cytotoxic activity of 17 led to a lower SI. Compounds 12, 15 and 26 were species specific. For T. cruzi, the SI was higher for 11, 15 and 26 than for the reference drugs nifurtimox and benznidazole. The examination of promastigote morphology after exposing L. mexicana and T. cruzi to 11 revealed a decrease in cell density. The current findings suggest that 11 could be a useful lead compound for further SAR studies.

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85061582341&origin=inward

UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85061582341&origin=inward

U2 - 10.1016/j.ejmech.2019.02.028

DO - 10.1016/j.ejmech.2019.02.028

M3 - Article

C2 - 30784876

SP - 402

EP - 413

JO - European Journal of Medicinal Chemistry

JF - European Journal of Medicinal Chemistry

SN - 0223-5234

ER -